WeiQing Zhou is a co-founder and Chief Operating Officer of LifeMine Therapeutics where she oversees and drives corporate development and communications, finance, operations and human resources. As an Entrepreneur-in-Residence at WuXi Healthcare Ventures, WeiQing co-led the team that developed LifeMine from a concept to a seed-stage company to a fully operational biotech company financed by a powerful international investor syndicate.

Prior to LifeMine, WeiQing co-founded FOG Pharmaceuticals with Gregory Verdine and Sir David Lane, and continues to serve as FogPharma’s Chief Operating Officer. Prior to FogPharma, WeiQing spent much of her career in corporate strategy, business development and product development at MedSkin Solutions Dr. Suwelack, Germany, having risen through positions of increasing responsibility to General Manager, with responsibility for global marketing, business development and commercialization. She holds an M.B.A. from the University of Dortmund, Germany.